Basit öğe kaydını göster

dc.contributor.authorPetek Erpolat, Ozge
dc.contributor.authorYuce Sari, Sezin
dc.contributor.authorErgen, Sefika Arzu
dc.contributor.authorAydin, Barbaros
dc.contributor.authorAkkus, Berna
dc.contributor.authorGultekin, Melis
dc.contributor.authorYildiz, Ferah
dc.date.accessioned2020-06-21T13:05:08Z
dc.date.available2020-06-21T13:05:08Z
dc.date.issued2019
dc.identifier.issn1300-7467
dc.identifier.urihttps://doi.org/10.5505/tjo.2019.1981
dc.identifier.urihttps://hdl.handle.net/20.500.12712/11108
dc.descriptionErgen, Sefika Arzu/0000-0002-7819-2335en_US
dc.descriptionWOS: 000483636700007en_US
dc.description.abstractOBJECTIVE To compare the tumor characteristics, treatment approaches, recurrence patterns and survival results rates of young and elderly patients with breast cancer. METHODS In this study, Between between 2000-2013, a total of 779 patients were treated for breast cancer at nine radiation oncology departments were evaluated retrospectively. Three-hundred eight four of these patients were young (<= 35 years), and 395 of those the patients were elderly (>= 70 years). RESULTS Young patients were more likely to present with aggressive tumor features. They were more often received comprehensive lymphatic irradiation, tumor bed boost and intense chemotherapy. No difference was found for 5 and 10-year loco-regional recurrence- free survival rates were (96% and 93% for young, 97% and 97% for elderly). The 5 and 10-year distant recurrence- free survival rates were lower in the young patients (77% and 67% for young, 85% and 85% for elderly, p<0.0001). No difference was found in 5 and 10-year breast cancer- specific survival (91% and 79% for young, 92% and 87% for elderly). The 5 and 10-year overall survival rates were higher in the young patients (92% and 78% for young, 78% and 63% for elderly, p<0.0001). CONCLUSION The reason for the similarity between the age groups in terms ofregarding loco-regional recurrence- free survival can be more comprehensive lymphatic irradiation and tumor bed boost, the young patients received. The distant recurrence- free survival rates rates were significantly lower in the young patients even though they received more intensive chemotherapy. Future studies aimed at more effective systemic regimens to decrease distant recurrence in young patients are warranted.en_US
dc.language.isoengen_US
dc.publisherKare Publen_US
dc.relation.isversionof10.5505/tjo.2019.1981en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBreast canceren_US
dc.subjectdistant metastasisen_US
dc.subjectelderly patientsen_US
dc.subjectloco-regional relapseen_US
dc.subjectyoung ageen_US
dc.titleThe Comparision of Breast Cancer in the Young and Elderly Patientsen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume34en_US
dc.identifier.issue3en_US
dc.identifier.startpage179en_US
dc.identifier.endpage188en_US
dc.relation.journalTurk Onkoloji Dergisi-Turkish Journal of Oncologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster